Myriad Products

Myriad is a biopharmaceutical company focused on the development of novel healthcare products. In addition to an expanding drug development pipeline, our drug discovery and development is strong in the areas of Alzheimer's disease, cancer and antivirals. We also develop and market predictive and personalized medicine products and forensic services.

Pharmaceuticals

At Myriad, we believe that the future of medicine will be in the creation of new drugs that prevent disease from initially developing or progressing by treating the cause, not just its symptoms. We believe that we can identify these disease-causing mechanisms and develop drug compounds to address them effectively. In addition to a strong preclinical pipeline that is rapidly moving toward human clinical testing, we are very excited about the future of several first-in-class compounds in the clinic that address large, unmet patient needs. We are currently running six clinical trials in the areas of Alzheimer's disease, brain metastases, solid tumors, blood cancers and thrombosis. Going forward, we will continue to focus on drug discovery for Alzheimer's, cancer, and antivirals with comprehensive biological research capabilities in all three areas.

Predictive Medicine & Genetic Testing

Myriad is a world leader in cancer predictive medicine. Individuals with early onset cancer or a history of cancer in their family use these products to determine their future cancer risk. In the battle against cancer, knowing your risk can save your life. Risk can be managed and cancer may be averted through appropriate precautions. If the disease is diagnosed early, it may be treated more successfully through a variety of proven options.